Cargando…

A New Synuclein-Transgenic Mouse Model for Early Parkinson’s Reveals Molecular Features of Preclinical Disease

Understanding Parkinson’s disease (PD), in particular in its earliest phases, is important for diagnosis and treatment. However, human brain samples are collected post-mortem, reflecting mainly end-stage disease. Because brain samples of mouse models can be collected at any stage of the disease proc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrickx, Diana M., Garcia, Pierre, Ashrafi, Amer, Sciortino, Alessia, Schmit, Kristopher J., Kollmus, Heike, Nicot, Nathalie, Kaoma, Tony, Vallar, Laurent, Buttini, Manuel, Glaab, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219584/ https://www.ncbi.nlm.nih.gov/pubmed/32997293 http://dx.doi.org/10.1007/s12035-020-02085-z

Ejemplares similares

Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease
por: Garcia, Pierre, et al.
Publicado: (2022)

Integrated metabolic modelling reveals cell-type specific epigenetic control points of the macrophage metabolic network
por: Pacheco, Maria Pires, et al.
Publicado: (2015)

RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples
por: Nazarov, Petr V., et al.
Publicado: (2017)

Comparative transcriptome analysis of Parkinson’s disease and Hutchinson-Gilford progeria syndrome reveals shared susceptible cellular network processes
por: Hendrickx, Diana M., et al.
Publicado: (2020)

Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson’s disease
por: Schmit, Kristopher J., et al.
Publicado: (2023)

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
por: Lindestam Arlehamn, Cecilia S., et al.
Publicado: (2020)

Computational systems biology approaches for Parkinson’s disease
por: Glaab, Enrico
Publicado: (2017)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Passive Immunization in Alpha-Synuclein Preclinical Animal Models
por: Folke, Jonas, et al.
Publicado: (2022)

Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
por: Nim, Satra, et al.
Publicado: (2023)

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
por: Masliah, Eliezer, et al.
Publicado: (2011)

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
por: Chen, Xi, et al.
Publicado: (2015)

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s disease
por: Yan, Yaping, et al.
Publicado: (2021)

Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
por: Argyrofthalmidou, Maria, et al.
Publicado: (2021)

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
por: Han, Jung-Youn, et al.
Publicado: (2021)

Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease
por: Chen, Qian-Qian, et al.
Publicado: (2018)

Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
por: Lohmann, Stephanie, et al.
Publicado: (2022)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease
por: Tian, Ye, et al.
Publicado: (2021)

Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype
por: Faustini, Gaia, et al.
Publicado: (2022)

Swimming exercise reduces native ⍺-synuclein protein species in a transgenic C. elegans model of Parkinson’s disease.
por: Schmidt, Minna Y., et al.
Publicado: (2021)

Systems level analysis of sex-dependent gene expression changes in Parkinson’s disease
por: Tranchevent, Léon-Charles, et al.
Publicado: (2023)

Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice
por: Mendritzki, Sonja, et al.
Publicado: (2010)

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain
por: Cronin, Kenneth D., et al.
Publicado: (2009)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
por: Rockenstein, Edward, et al.
Publicado: (2016)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function
por: Nazarov, Petr V., et al.
Publicado: (2013)

Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease
por: Bellucci, Arianna, et al.
Publicado: (2011)

Developmental Changes in Dendritic Spine Morphology in the Striatum and Their Alteration in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Parajuli, Laxmi Kumar, et al.
Publicado: (2020)

Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson’s Disease
por: Portz, Philipp, et al.
Publicado: (2021)

Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice
por: Bachurin, Sergey O., et al.
Publicado: (2011)

Effects of α-Synuclein Overexpression in Transgenic Caenorhabditis elegans Strains
por: Bodhicharla, Rakesh, et al.
Publicado: (2012)

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
por: Li, Yang, et al.
Publicado: (2022)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_srv87rnfu92beoplglg8fbnsgc